498 related articles for article (PubMed ID: 32509600)
1. Targeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response.
Pierce S; Geanes ES; Bradley T
Front Cell Infect Microbiol; 2020; 10():231. PubMed ID: 32509600
[TBL] [Abstract][Full Text] [Related]
2. Memory-like natural killer cells for cancer immunotherapy.
Gang M; Wong P; Berrien-Elliott MM; Fehniger TA
Semin Hematol; 2020 Oct; 57(4):185-193. PubMed ID: 33256911
[TBL] [Abstract][Full Text] [Related]
3. Natural Killer Cells: The Linchpin for Successful Cancer Immunotherapy.
Shaver KA; Croom-Perez TJ; Copik AJ
Front Immunol; 2021; 12():679117. PubMed ID: 33995422
[TBL] [Abstract][Full Text] [Related]
4. Tricking the balance: NK cells in anti-cancer immunity.
Pahl J; Cerwenka A
Immunobiology; 2017 Jan; 222(1):11-20. PubMed ID: 26264743
[TBL] [Abstract][Full Text] [Related]
5. Hidden talents of natural killers: NK cells in innate and adaptive immunity.
Cooper MA; Colonna M; Yokoyama WM
EMBO Rep; 2009 Oct; 10(10):1103-10. PubMed ID: 19730434
[TBL] [Abstract][Full Text] [Related]
6. The role of natural killer cells in tumor control--effectors and regulators of adaptive immunity.
Wallace ME; Smyth MJ
Springer Semin Immunopathol; 2005 Jun; 27(1):49-64. PubMed ID: 15729567
[TBL] [Abstract][Full Text] [Related]
7. Is There Natural Killer Cell Memory and Can It Be Harnessed by Vaccination? Natural Killer Cells in Vaccination.
Neely HR; Mazo IB; Gerlach C; von Andrian UH
Cold Spring Harb Perspect Biol; 2018 Oct; 10(10):. PubMed ID: 29254978
[TBL] [Abstract][Full Text] [Related]
8. The Natural Killer-Dendritic Cell Immune Axis in Anti-Cancer Immunity and Immunotherapy.
Peterson EE; Barry KC
Front Immunol; 2020; 11():621254. PubMed ID: 33613552
[TBL] [Abstract][Full Text] [Related]
9. Innate or adaptive immunity? The example of natural killer cells.
Vivier E; Raulet DH; Moretta A; Caligiuri MA; Zitvogel L; Lanier LL; Yokoyama WM; Ugolini S
Science; 2011 Jan; 331(6013):44-9. PubMed ID: 21212348
[TBL] [Abstract][Full Text] [Related]
10. Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy.
Wu Y; Li J; Jabbarzadeh Kaboli P; Shen J; Wu X; Zhao Y; Ji H; Du F; Zhou Y; Wang Y; Zhang H; Yin J; Wen Q; Cho CH; Li M; Xiao Z
Pharmacol Res; 2020 May; 155():104691. PubMed ID: 32070721
[TBL] [Abstract][Full Text] [Related]
11. Balancing act: the complex role of NK cells in immune regulation.
Jiang H; Jiang J
Front Immunol; 2023; 14():1275028. PubMed ID: 38022497
[TBL] [Abstract][Full Text] [Related]
12. [Natural killer cells: adaptation and memory in innate immunity].
Narni-Mancinelli E; Ugolini S; Vivier E
Med Sci (Paris); 2013 Apr; 29(4):389-95. PubMed ID: 23621934
[TBL] [Abstract][Full Text] [Related]
13. Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies.
Medina-Echeverz J; Hinterberger M; Testori M; Geiger M; Giessel R; Bathke B; Kassub R; Gräbnitz F; Fiore G; Wennier ST; Chaplin P; Suter M; Hochrein H; Lauterbach H
Nat Commun; 2019 Nov; 10(1):5041. PubMed ID: 31695037
[TBL] [Abstract][Full Text] [Related]
14. Natural killer cells, ageing and cancer.
Naumova E; Pawelec G; Mihaylova A
Cancer Immunol Immunother; 2016 Apr; 65(4):367-70. PubMed ID: 26969613
[TBL] [Abstract][Full Text] [Related]
15. Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells.
Kim N; Kim HS
Front Immunol; 2018; 9():2041. PubMed ID: 30250471
[TBL] [Abstract][Full Text] [Related]
16. Natural Killer Cell Engagers (NKCEs): a new frontier in cancer immunotherapy.
Zhang M; Lam KP; Xu S
Front Immunol; 2023; 14():1207276. PubMed ID: 37638058
[TBL] [Abstract][Full Text] [Related]
17. NK cells interactions with dendritic cells shape innate and adaptive immunity.
Brilot F; Strowig T; Munz C
Front Biosci; 2008 May; 13():6443-54. PubMed ID: 18508671
[TBL] [Abstract][Full Text] [Related]
18. Roles of natural killer cells in antiviral immunity.
Waggoner SN; Reighard SD; Gyurova IE; Cranert SA; Mahl SE; Karmele EP; McNally JP; Moran MT; Brooks TR; Yaqoob F; Rydyznski CE
Curr Opin Virol; 2016 Feb; 16():15-23. PubMed ID: 26590692
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional interactions of NK cells and dendritic cells in immunotherapy: current and future perspective.
Mahmood S; Upreti D; Sow I; Amari A; Nandagopal S; Kung SK
Immunotherapy; 2015; 7(3):301-8. PubMed ID: 25804481
[TBL] [Abstract][Full Text] [Related]
20. Natural killer cell epigenetic reprogramming in tumors and potential for cancer immunotherapy.
Hojjatipour T; Maali A; Azad M
Epigenomics; 2023 Feb; 15(4):249-266. PubMed ID: 37125432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
